Related references
Note: Only part of the references are listed.An ecological and evolutionary perspective on human-microbe mutualism and disease
Les Dethlefsen et al.
NATURE (2007)
Effectiveness of influenza vaccine in the community-dwelling elderly
Kristin L. Nichol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia
Julie L. McAuley et al.
CELL HOST & MICROBE (2007)
The 1918 influenza pandemic: Insights for the 21st century
David M. Morens et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
Menno D. de Jong et al.
NATURE MEDICINE (2006)
Insights into the interaction between influenza virus and pneumococcus
Jonathan A. McCullers
CLINICAL MICROBIOLOGY REVIEWS (2006)
Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin
BK English et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Early vancomycin therapy and adverse outcomes in children with pneumococcal
SC Buckingham et al.
PEDIATRICS (2006)
Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection
BE Gonzalez et al.
CLINICAL INFECTIOUS DISEASES (2005)
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone
EG Vázquez et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Group B streptococci exposed to rifampin or clindamycin (versus ampicillin or cefotaxime) stimulate reduced production of inflammatory mediators by murine macrophages
KC Brinkmann et al.
PEDIATRIC RESEARCH (2005)
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes
JS Francis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
LM Baddour et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza
JA McCullers
JOURNAL OF INFECTIOUS DISEASES (2004)
A role for Streptococcus pneumoniae in virus-associated pneumonia
SA Madhi et al.
NATURE MEDICINE (2004)
Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital
SC Buckingham et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Selective screening for complement deficiencies in patients with meningococcal disease
SJ Hackett et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
An international prospective study of pneumococcal bacteremia: Correlation with in vitro resistance, antibiotics administered, and clinical outcome
VL Yu et al.
CLINICAL INFECTIOUS DISEASES (2003)
Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae
JA McCullers et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
JA Martínez et al.
CLINICAL INFECTIOUS DISEASES (2003)
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?
CY Cheung et al.
LANCET (2002)
Lethal Synergism between influenza virus and Streptococcus pneumoniae:: Characterization of a mouse model and the role of platelet-activating factor receptor
JA McCullers et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Clinical trials of immunomodulatory therapies in severe sepsis and septic shock
JL Vincent et al.
CLINICAL INFECTIOUS DISEASES (2002)
Modulation of release of proinflammatory bacterial compounds by antibacterials: Potential impact on course of inflammation and outcome in sepsis and meningitis
R Nau et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Oral oseltamivir treatment of influenza in children
RJ Whitley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Effects of antibiotic class on the macrophage inflammatory response to Streptococcus pneumoniae
KL Orman et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
DR Feikin et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Share Paper
